• DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi - Best Science for the Most Neglected 20 Years
  • DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

DNDi Innovation & Access – Partners’ Meeting 2016

6-8 June 2016

Rio de Janeiro, Brazil

Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print
  • Information and programme
    • Information and programme
    • Photos
Print

DNDi Latin America organized a series of events with conferences, discussions and meetings. The final event, the Partners’ Meeting, took place on June 8th 2016 in Rio de Janeiro, Brazil. Participants from the field of research & development on neglected diseases, including international scientists, product developers, policy-makers, and civil society organizations, participated in the events in order to promote the best science for the most neglected.

Download the Full Programme

Partners’ Meeting

Date: June 8, 2016
Venue: Hotel Rio Othon Palace Av. Atlantica, 3264 – Copacabana

Opening Ceremony

Time: 08:30-10:00

 WelcomeMarcel Tanner, DNDi Board Chair and Professor and Chair of Epidemiology & Medical Parasitology, University of Basel & Federal Institute of Technology, Switzerland
Opening Addresses
Alejandro Gaviria Uribe, Minister of Health & Social Protection of Colombia

Jorge Bermudez, Vice President of Health Production & Innovation, Fiocruz, Minister of Health of Brazil

Innovation & access for neglected populations, a dynamic approach towards 2023
Bernard Pécoul,
Executive Director, DNDi

Key challenges and prospects for Latin America
Joël Keravec, Regional Executive Director, DNDi Latin America
 Closing Remarks
Joël Keravec, Regional Executive Director, DNDi Latin America

Panel Discussions

10:30-11:30 Session 1: Innovation & access for Chagas disease
Chair: Mercedes Tatay, International Medical Secretary, MSF Switzerland
Respondents:
– Sergio Sosa-Estani, Director, Insituto Fatala Chaben
– Nancy Dominga da Costa, President of the Rio Chagas Association
– Marcelo Paganini, Executive Director, Mundo Sano
– Isabela Ribeiro, Head of Chagas Clinical Program, DNDi
-Oscar Bernal, Director of the Master’s in Public Health Program, Los Andes University
 
11:30-12:30 Session 2: Innovation & access for Leishmaniasis
Chair: Renato Alves, Head of the Vector Born Disease Unit, Ministry of Health Brazil
Respondents:
– Ivano Dario Velez, Director, PECET, University of Antioquia
– Ana Nilce Elkhoury, Regional Advisor of Leishmaniasis, PAHO
– Gustavo Romero, Professor, University of Brazil
– Moacir Zini, Patient Representative, Mato Grosso State
– Byron Arana, Head of Cutaneous Leishmaniasis, DNDi
 
14:00-14:45 Keynote Discussion
Zika, Chagas, Hepatitis C: From emergencies to Sustainable Innovation & Access in Latin America and the Rest of the World
Chair: Marcel Tanner, DNDi Board Chair, Professor & Chair of Epidemiology & Medical Parasitology, University of Basel & Federal Institute of Technology, Switzerland
Respondents:

– Nick White, Professor of Tropical Medicine, Mahidol University
– Nila Heredia, President, ASOFAMD and Former Minister of Health & Sports, Bolivia
– Noor Hisham Abdullah, Director General of Health, Ministry of Health, Malaysia
 
14:45-15:45 Session 3: The role of innovative funding initiatives for global health needs
Chair: Dr Els Torreele, Director, Access to Essential Medicines, Open Society Foundations
Respondents:
– Elkin Echeverri, Director of Planning and Strategy, Ruta N
– João Paulo Pieroni, Head of Pharmaceutical Products, BNDES
– Draurio Barreira, Manager, Tuberculosis, Strategy and Results, UNITAID
– Joël Keravec, Regional Executive Director, DNDi Latin America
– Suerie Moon, Research Director at the Harvard School of Public Health
 
15:45-16:45Session 4: How to address emerging public health challenges & priorities
Chair: Nirmal K. Ganguly, Advisor and Professor, Translational Health Science & Technology Institute, India National Institute of Immunology
Respondents:
– Claudia Vaca, Pharmacoepidemiologist, Professor at the Department of Pharmacy, National University, Colombia
– Manica Balasegaram, Director, Global Antibiotic R&D (GARD, DNDi) Partnership
– Yasser Mohamed Fayed, Business Development Director,  Pharco Pharmaceuticals
– Jorge Bermudez, Vice President of Health Production and Innovation, Fiocruz
– Bernard Pécoul, Executive Director, DNDi
 

Closing Ceremony

17:00-18:00 Closing Remarks: Awards and Farewell
Chair: Prof Marcel Tanner, Chair
– Project of the Year
– Partnership of the Year
– Innovative Funding Mechanism

Download the Full Programme

Chagas Platform Meeting & Workshops

Workshops

Date: June 6, 2016
Venue: Hotel Rio Othon Palace Av. Atlantica, 3264 – Copacabana

Workshop 1 – 08:30-13:00
Meeting Room: Copacabana A
Discovery of new drugs for leishmaniasis and Chagas disease
Moderator:Eric Chatelain, DNDi / Fabiana Barreira, DNDi
Workshop 2 – 08:30-12:30
Meeting Room:
Copacabana B
Mini-course: Preparation of scientific articles
Moderator: Ronald Henry, Centers for Disease Control and Prevention / Marina Boni, DNDi
Workshop 3 – 08:30-13:00
Meeting Room:
Bossa
Strengthening the Chagas education for health careers
Moderator: Edgardo Moretti, Universidad Nacional de Córdoba, Argentina / Jorge Pedro Martin, DNDi
Workshop 4 – 08:30-13:30
Meeting Room:
Pontal
CLOSED MEETING
Update on qPCR validation and quality control for diagnosis and monitoring of Chagas disease patients
Moderator: Zaida Yadón, WHO/OMS /  Alejandro Schijman, INGEBI-CONICET / Erika Correira, DNDi
Workshop 5 – 14:00-18:30
Meeting Room:
Copacabana A

Theoretical and practical workshop on the diagnosis, treatment and monitoring of children with congenital Chagas disease – RED PEDCHAGAS
Moderator: Jaime Altcheh, Hospital de Niños R. Gutiérrez de Buenos Aires / Christina Alonso Vega, DNDi
Workshop 6 – 14:00-18:30
Meeting Room:
Copacabana B

Interface between civil society and NGOs to tackle NTDs: Prospectives on opportunites and challenges
Moderator: Alberto Novaes Ramos Jr., Universidade Federal do Ceará / Marina Certo, DNDi
Workshop 6 – 14:00-18:30
Meeting Room: São Conrado
CLOSED MEETING
New research fields and guidelines for Chagas disease
Moderator: Sergio Sosa-Estani, INP Fatela Chaben, MoH Argentina, Andrea Marchiol, DNDi
Workshop 7 – 14:00-16:00
Meeting Room:
Bossa

Barriers and strategies of access to treatments for Leishmaniasis
Moderator: Carolina Batista DNDi / Joelle Rode, DNDi
Workshop 8 – 16:15-18:30
Meeting Room:
Bossa
Current status and perspective of Leishmaniasi diagnosis in the American region
Moderator: Zaida Yadón WHO/OMS / Mady Malheiros Barbeitas, DNDi

Sessions

Date: June 7, 2016
Venue: Hotel Rio Othon Palace Av. Atlantica, 3264 – Copacabana

8:30-09:30Discovery of new drugs for leishmaniasis and Chagas disease
Moderator: Eric Chatelain, DNDi, Geneva
Speakers:

– Luiz Carlos Dias, UNICAMP
– Carolina Borsoi Moraes, LNBio
– Facundo García-Bournissen, Hospital de Niños R. Gutiérrez de Buenos Aires
– John Kelly, London School of Hygiene & Tropical Medicine
– Momar Ndao, McGill University
9:30-10:30Vaccines for Chagas disease: strategies and current studies overview
Moderator: Maria Elena Bottazzi, Sabin Vaccine Institute Product Development Partnership
Speakers:
– Kathryn Jones, Sabin Vaccine Institute e Texas Children’s Hospital Center for Vaccine Development
– Igor Almeida, University of Texas at El Paso – UTEP
– Ricardo Gazzinelli, Fundação Oswaldo Cruz – Fiocruz

INTERVAL – COFFEE BREAK

10:45-12:30The new landscape for chronic patients based on current knowledge
Moderator: Sergio Sosa-Estani, INP Fatala Chaben – ANLIS – MSN, Argentina
Speakers:
– Rodolfo Viotti, Hospital Eva Perón, Buenos Aires, Argentina
– Anis Rassi Junior, Hospital Anis Rassi – Goiânia

LUNCH

14:00-15:00 Updates on clinical trials studies for Chagas disease – where we are and future prospects
Moderator: Rodolfo Viotti, Hospital Eva Perón
Speakers:
– Jaime Altcheh, Hospital de Niños R. Gutiérrez de Buenos Aires
– Israel Molina, HU Vall Hebron-PROSICS Barcelona
– María Gabriela Álvarez, Hospital Eva Perón, Buenos Aires
– Tania C. de Araújo-Jorge, IOC – Fiocruz
– Joaquim Gascon, ISGlobal
15:00-15:50 New trends and challenges for Chagas: Integrative therapy approach and oral Chagas disease
Moderator: Israel Molina, HU Vall Hebron-PROSICS, Barcelona
Speakers:
– Andréa Silvestre de Sousa, INI – Fiocruz
– Belkisyolé Alarcón de Noya, Inst. Medicina Tropical, UCV
– Ana Yecê das Neves Pinto, IEC – Fiocruz

COFFEE BREAK

16:00-17:30 Transforming evidence into public health policy: operational research and challenges in access
Moderator: Lucia Brum, MSF Brazil
Speakers:
– Silvia Moriana, Coalición Global de la Enfermedad de Chagas
– Renato Alves, Secretaria de Vigilância em Saúde do Ministério da Saúde, Brasil
– Cynthia Spillmann, Programa Nacional de Chagas del Ministerio de Salud de la Nación, Argentina
– Eduin Pachón Abril, Ministerio de Salud y Protección Social, Colombia)
17:30-17:40 Closing remarks and follow up
Jorge Pedro Martin, DNDi / Carolina Batista DNDi / Fabiana Barreira, DNDi
18:00-22:30Social Cocktail
Solar Real Santa Teresa – transfer 6pm from the hotel lobby

Download the Full Programme

RedeLeish Meeting

Date: June 7, 2016
Venue: Hotel Rio Othon Palace Av. Atlantica, 3264 – Copacabana
 

08:30-09:15 Feedback from workshops and closed meetings
– Piero Olliaro, TDR/OMS
– Ana Rabello, Fiocruz
– Marina Boni, DNDi
– Jadel Kratz, DNDi
09:15-09:45 Status of clinical studies and portfolio of DNDi CL
Byron Arana, DNDi

INTERVAL

10:00-11:00Methods for implementing more economical clinical trials
Piero Olliaro, TDR/OMS (WHO)
11:00-11:30Clinical trials Walter Reed Army Institute: Paromomycin cream and Gentamicin
Max Grogl, U.S. Naval Medical Research Unit No. 6 (NAMRU-6)
11:30-12:00State of the art: Nanotechnology and development of local treatments
Bartira Bergmann, Universidade Federal do Rio de Janeiro
12:00-12:30State of the Art: Topical formulations for the treatment of CL
Antonia Franco, Instituto Nacional de Pesquisa da Amazônia

LUNCH

14:00-14:30State of the art: Development of HMP as a leishmanicide agent
Edilene Oliveira, UFPA, Universidade Federal do Pará
14:30-15:00Clinical trial of pharmacokinetics of miltefosine in adults and children
María del Mar Castro, CIDEIM – Centro Internacional de Entrenamiento e Investigaciones Médicas
15:00-15:30Preliminary results of circulating Leishmania species identification study in the states of Pará, Acre and Mato Grosso
Lourdes Garcez, Instituto Evandro Chagas, Ministério da Saúde

COFFEE BREAK

15:45-16:15Update of the rapid test development for the diagnosis of CL
Isra Cruz, Foundation of Innovative New Diagnostics (FIND)
16:15-16:30Lessons learned from the network model to approach clinical trials in CL and the applicability of this model in the Old World
Farhad Handjani, Shiraz University of Medical Sciences
16:30-16:50Webforum: Operation and discussions
Mady Malheiros Barbeitas, redeLEISH Coordinator, DNDi Latin America
16:50-17:10WorldLeish 6
Jorge Alvar, DNDi
17:00-17:30Closing remarks and follow up
Byron Arana, DNDi / Joelle Rode, DNDi Latin America
18:00-22:30Social Cocktail
Solar Real Santa Teresa – transfer 6pm from the hotel lobby

Download the Full Programme

At the meeting, DNDi recognized the work of Latin American partners for NTD research.

The Innovative Funding Mechanism Award

Ruta N Medellín, an organization based in Medellin, Colombia, which focuses on knowledge as a primary source for research and development, was awarded the Innovative Funding Mechanism Award for its funding of leishmaniasis.

Partners_Meeting_Week_DNDi_048_enews
Representatives from Ruta N Medellin accepting their Innovative Funding Mechanism of the Year Award, with Prof Marcel Tanner and Cecilia Castillo, DNDi

The Partnership of the Year Award

The Partnership of the Year Award was presented to LOLA, a Latin American Lead Optimization Programme. The LOLA project uses an international collaborative approach, working with UNICAMP (University of Campinas) with partners in the USA (AbbVie) and Europe (LMPH, University of Antwerp, Belgium) to carry out early stage drug discovery and sets a precedent for all emerging neglected disease endemic countries.

June_enews_Partners_Meeting_Week_DNDi_049
 
  • LOLA team members
  • Prizegiving DNDi 2016 Partners' Meeting, Rio, Brazil

Pages: Page 1, Page 2

Other events

Loading...
8-12 May 2023

Lisbon, Portugal and online

ESPID 2023

13 April 2023, 2 PM London

London, United Kingdom

Ending the neglect of Chagas disease in the UK

11-12 April 2023

Barcelona, Spain and online

XVIII Jornadas sobre la enfermedad de Chagas

27-31 March 2023

Online

Global meeting on skin-related neglected tropical diseases

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

DNDi - Best Science for the Most Neglected 20 Years
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License   
We use cookies to track our audience and improve our content. By clicking 'Accept All', you are agreeing to our use of cookies. Click on 'Customize' to accept only some cookies.
Customize
REJECT ACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSIDsessionThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
elementorneverThis cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_16Q5RH3XRG2 yearsThis cookie is installed by Google Analytics.
_gat_UA-10302561-11 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
_hjAbsoluteSessionInProgress30 minutesHotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
_hjFirstSeen30 minutesHotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
_hjIncludedInPageviewSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
_hjIncludedInSessionSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's daily session limit.
_hjSession_112884430 minutesHotjar sets this cookie.
_hjSessionUser_11288441 yearHotjar sets this cookie.
CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
Targeting
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
SAVE & ACCEPT
Powered by CookieYes Logo